Charles River Laboratories International Inc (NYSE:CRL)
$ 209.8 1.39 (0.67%) Market Cap: 10.81 Bil Enterprise Value: 13.49 Bil PE Ratio: 24.62 PB Ratio: 2.97 GF Score: 95/100

Charles River Laboratories International Inc at Barclays Global Healthcare Conference Transcript

Mar 13, 2019 / 02:15PM GMT
Release Date Price: $141.51 (+0.73%)
Jack Meehan
Barclays Bank PLC, Research Division - VP & Senior Research Analyst

Well, thank you, and good morning. I'm Jack Meehan, the Barclay's licensed tools, diagnostics analyst. I'm pleased to be joined by Jim Foster, the Chairman and CEO of Charles River Labs. Maybe to kick off, we're going to just get some audience response questions. If you see the Blackberrys in front of you. First question, how do you view Charles River's organic growth profile over the next 3 years? We'll get the answer later from Jim.

(Voting)

Jack Meehan;Jack Meehan
Barclays Bank PLC, Research Division - VP & Senior Research Analyst;Barclays Bank PLC, Research Division - VP & Senior

We did get a strategy update over the summer, so we'll compare and contrast. Mostly in the mid-single-digits blend around that.

Second question, do you expect organic growth to accelerate from current levels and when? I would note some of the recent growth has been pretty robust. But let's see what the audience thinks.

(Voting)

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot